SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-006865
Filing Date
2019-02-08
Accepted
2019-02-08 17:19:16
Documents
2
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLIDOUGLAS E. ONSIHAROLD WERNERHEALTHCARE PARTNERS IX, L.P.HEALTHCARE PARTNERS IX, LLCHEALTHCARE PARTNERS VIII, L.P.HEALTHCARE PARTNERS VIII, LLCHEALTHCARE STRATEGIC PARTNERS, LLCHEALTHCARE VENTURES STRATEGIC FUND, L.P.HE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-4220_1sc13da.htm SC 13D/A 391317
2 EX-99.1 a19-4220_1ex99d1.htm EX-99.1 75388
  Complete submission text file 0001104659-19-006865.txt   468865
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142 617.252.4343
HealthCare Ventures IX, L.P. (Filed by) CIK: 0001490245 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90188 | Film No.: 19581045
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1